The presence of the PRMT5 methylosome complex, specifically the COPR5 variant (CPX‐8149), in the Tau‐F P301L mutant interactome suggests a distinct regulatory mechanism relevant to AD. This evidence concerns the gene MAPT and Alzheimer disease.